Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Thermo Fisher Scientific

US

Last updated May 23, 2026

What Thermo Fisher Scientific makes

Thermo Fisher Scientific manufactures automated specimen processing instruments for laboratory use, including recappers and storage systems, as well as multiple clinical chemistry analysers for routine laboratory testing. Their portfolio includes susceptibility testing systems for antimicrobial resistance, such as MIC/Breakpoint plates and systems for antibiotics like ceftolozane/tazobactam, imipenem-relebactam, and cefiderocol. Additional products include immunoassay analysers for allergen and immunoglobulin testing, as well as yeast susceptibility testing systems for antifungal agents.

These devices are regulated under FDA Class I and Class II classifications, with many authorised via the 510(k) pathway and listed under the FDA’s Unique Device Identifier (UDI) system. The company’s products are intended for in vitro diagnostic use in clinical and research settings.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (81)

Page 2 of 2
DeviceModel / ReferenceRegistriesClassStatus
Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint, Susceptibility System with Lefamulin in the dilution range of 0.008-16ug/mL K193024
FDA 510(k)
Class IIActive
Qms Lidocaine Calibrators, Model 0374678 K091617
FDA 510(k)
Class IIActive
Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mL K211539
FDA 510(k)
Class IIActive
Sensititre 20-24 hour Haemophilus influenzae /Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dtest (containing erythromycin at 1 ug/mL and clindamycin at 0.5 ug/mL) K202612
FDA 510(k)
Class IIActive
Calcium, Scal, Nortrol, Abtrol K073355
FDA 510(k)
Class IIActive
Sensititre HP MIC Susceptibility Plate with Tedizolid (0.002-4 mcg/ml) K142338
FDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution range of 0.004-8 ug/mL K172454
FDA 510(k)
Class IIActive
Cedia Mycophenolic Acid Assay, Calibrators, Mas Mycophenolic Acid Controls K081083
FDA 510(k)
Class IIActive
Thermo Scientific Sensititre ARIS HiQ System K191918
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftazidime/Avibactam in the dilutions range of 0.015/4 - 32/4 ug/mL K152774
FDA 510(k)
Class IIActive
Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Omadacycline in the dilution range of 0.008 - 32 ug/mL K183324
FDA 510(k)
Class IIActive
Urea/Bun, Scal, Nortrol, Abtrol K073295
FDA 510(k)
Class IIActive
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.12-32 ug/mL K242905
FDA 510(k)
Class IIActive
Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC, or Breakpoint Susceptibility System with Imipenem-relebactam in the dilution, range of 0.03/4-128-4ug/ml (Haemophilus influenzae) K230935
FDA 510(k)
Class IIActive
Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mL K221198
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL K250990
FDA 510(k)
Class IIActive
Xpect Flu A & B K092423
FDA 510(k)
Class IIActive
Sensititre 18-24 Hour MIC or Breakpoint Susceptibility System with Lefamulin in the dilution range of 0.008-16ug/ml K192729
FDA 510(k)
Class IIActive
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution range of 0.00025-8µg/mL K172274
FDA 510(k)
Class IIActive
Alkaline Phosphatase (ifcc) Plus, Ecal, Nortrol, Abtrol K073191
EUDAMEDFDA 510(k)
Class IIActive
Uric Acid (aox), Scal, Nortrol, Abtrol K073612
FDA 510(k)
Class IIActive
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL. K242843
FDA 510(k)
Class IIActive
Sensititre Susceptibility Plates K141000
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL K252014
FDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Meropenem/Vaborbactam in the Dilution Range of 0.008/8 - 18/8 ug/mL K173209
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.25-32 ug/mL K242653
FDA 510(k)
Class IIActive
Sensititre Susceptibility plates K143288
FDA 510(k)
Class IIActive
Ast/Got (ifcc), Pyridoxal Phosphate, Ecal, Nortrol And Abtrol K071580
EUDAMEDFDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Omadacycline in the dilution range of 0.03-32ug/ml K183033
FDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 µg/ml K193538
FDA 510(k)
Class IIActive
The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL K250575
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (5)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Thermo Fisher Scientific has five recall records initiated between July 24, 2007, and September 23, 2010, all of which are recorded as terminated. The reasons cited include the need for additional system validation to confirm disinfection efficacy, a deviation in the concentration of Buffered Formalin Phosphate from specified limits, potential assay interference from endogenous ALT in patient samples, and reported issues with specimen integrity and premature chamber rotation stopping.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Sep 23, 2010Z-1735-2011—terminated

Through internal quality review, firm determined the need to conduct a more comprehensive system validation to support the claim of complete bacterial, fungal and viral disinfection efficacy.

Sep 23, 2010Z-1734-2011—terminated

Through internal quality review, firm determined the need to conduct a more comprehensive system validation to support the claim of complete bacterial, fungal and viral disinfection efficacy.

Jun 3, 2009Z-1320-2010—terminated

The firm has received complaints regarding specimen integrity (higher rate of specimen fragmentation) as well as complaints that the chamber may stop rotating prematurely, resulting in sample deterioration.

May 1, 2008Z-2159-2008—terminated

Assay tests on retention sample of 10% Buffered Formalin Phosphate showed it to be 3.417%, which is below the specification of 4-5%.

Jul 24, 2007Z-0015-2008—terminated

Method is susceptible to positive interference from endogenous ALT in patient samples.